Skip navigation
Agenda

Manage Cost, Expand Access, Improve Patient Services and Care Delivery

January 25-26, 2018
  • Las Vegas, NV

Agenda

Want more agenda details? Download the brochure.

DAY ONE THURSDAY, JANUARY 25, 2018

7:30

Workshop Registration and Continental Breakfast

8:30

WORKSHOP Considerations for Accreditation and Expanding Reach for Specialty Pharmacies

I. Specialty Pharmacy Accreditation

II. Specialty Operations

III. Clinical Management

IV. Contracting and Network Participation

Workshop Leaders:

Nick Page
Vice President, Specialty and Clinical Operations
US Specialty Care

Doug Gebhard, PharmD, MBA
Vice President, Quality & Education
PANTHERx Specialty Pharmacy

There will be a 30-minute networking and refreshment break at 10:00am

12:00

Close of Workshop; Conference Registration and Refreshments

DAY ONE | MAIN CONFERENCE
THURSDAY, JANUARY 25, 2018

12:00

Registration and Refreshments

1:15

Chairperson’s Welcome and Opening Remarks

Katy Wong, RPh, MBA
Vice President, Producer Relations
CIGNA

1:30

Rebate Programs —
An Examination of How Rebates Affect Patients and Payments

Francis J. Rienzo
Vice President, Advocacy and Government Relations
Medicaid Health Plans of America (MHPA)

2:15

PANEL Multi-Stakeholder Examination of Value Frameworks and Their Implementation for Specialty Therapies

MODERATOR:

Joseph Fuhr
Professor of Economics
Thomas Jefferson University

PANELISTS:

Kayse Reitmeyer
Pharmaceutical Manufacturer Relations Director
Highmark Inc.

Peter Dehnel
Medical Director
CentraCare HealthSystem

Lyn Fitzgerald
Senior Vice President, U.S. and Global Development
National Comprehensive Cancer Network (NCCN)

Jeff Blake
Senior Vice President, Payer Relations
Hemophilia Alliance

3:00

Networking and Refreshment Break

3:30

CASE STUDY Managing High Cost Complex Conditions — A Case Study

Jeff Blake
Senior Vice President, Payer Relations
Hemophilia Alliance

4:15

Orphan Drugs — The Reinvention of Specialty Pharmacy?

Doug Gebhard, PharmD, MBA
Vice President, Quality & Education
PANTHERx Specialty Pharmacy

5:00

How Can Payers and Manufacturer Work Together to Establish Appropriate Utilization Guidelines

Mark Erwin
Principal
Square Hill Company

5:45

Close of Day One

Networking, Wine and Cheese Reception immediately following the final session on day one

DAY TWO | FRIDAY, JANUARY 26, 2018

8:00

Continental Breakfast

8:30

Chairperson’s Review of Day One

Katy Wong, RPh, MBA
Vice President, Producer Relations
CIGNA

8:45

Real World Therapy Management Program Response to PCSK9 Medications

Daniel Jude, PharmD, AAHIVP
Manager Specialty Clinical Services
Fairview Specialty Services Pharmacy

9:30

CASE STUDY Outcomes of a Voluntary Site of Care Program —
One Health Plan’s Experience

Leah King, PharmD, JD
Manager, Pharmacy Strategy
Highmark Inc.

10:15

Networking and Refreshment Break

10:45

ACA Update and Its Impact on Specialty Therapies

Melissa Andel
Health Policy Director
Applied Policy

11:30

Examining Drug Distribution Channels for Specialty Therapies

Carlos Alfaras
President and CEO
Gensco Pharma

12:15

Networking Luncheon

1:30

Considerations When Looking At Rare and Orphan Disease Treatments

Peter Dehnel
Medical Director
CentraCare HealthSystem

2:15

The Biosimilars Pipeline and Anticipated Access Barriers

Joseph Fuhr
Professor of Economics
Thomas Jefferson University

3:00

Chairperson’s Closing Remarks

Katy Wong, RPh, MBA
Vice President, Producer Relations
CIGNA

3:15

Close of Conference

Agenda

Want more agenda details? Download the brochure.
Want more agenda details? Download the brochure.

DAY ONE THURSDAY, JANUARY 25, 2018

7:30

Workshop Registration and Continental Breakfast

8:30

WORKSHOP Considerations for Accreditation and Expanding Reach for Specialty Pharmacies

I. Specialty Pharmacy Accreditation

II. Specialty Operations

III. Clinical Management

IV. Contracting and Network Participation

Workshop Leaders:

Nick Page
Vice President, Specialty and Clinical Operations
US Specialty Care

Doug Gebhard, PharmD, MBA
Vice President, Quality & Education
PANTHERx Specialty Pharmacy

There will be a 30-minute networking and refreshment break at 10:00am

12:00

Close of Workshop; Conference Registration and Refreshments

DAY ONE | MAIN CONFERENCE
THURSDAY, JANUARY 25, 2018

12:00

Registration and Refreshments

1:15

Chairperson’s Welcome and Opening Remarks

Katy Wong, RPh, MBA
Vice President, Producer Relations
CIGNA

1:30

Rebate Programs —
An Examination of How Rebates Affect Patients and Payments

Francis J. Rienzo
Vice President, Advocacy and Government Relations
Medicaid Health Plans of America (MHPA)

2:15

PANEL Multi-Stakeholder Examination of Value Frameworks and Their Implementation for Specialty Therapies

MODERATOR:

Joseph Fuhr
Professor of Economics
Thomas Jefferson University

PANELISTS:

Kayse Reitmeyer
Pharmaceutical Manufacturer Relations Director
Highmark Inc.

Peter Dehnel
Medical Director
CentraCare HealthSystem

Lyn Fitzgerald
Senior Vice President, U.S. and Global Development
National Comprehensive Cancer Network (NCCN)

Jeff Blake
Senior Vice President, Payer Relations
Hemophilia Alliance

3:00

Networking and Refreshment Break

3:30

CASE STUDY Managing High Cost Complex Conditions — A Case Study

Jeff Blake
Senior Vice President, Payer Relations
Hemophilia Alliance

4:15

Orphan Drugs — The Reinvention of Specialty Pharmacy?

Doug Gebhard, PharmD, MBA
Vice President, Quality & Education
PANTHERx Specialty Pharmacy

5:00

How Can Payers and Manufacturer Work Together to Establish Appropriate Utilization Guidelines

Mark Erwin
Principal
Square Hill Company

5:45

Close of Day One

Networking, Wine and Cheese Reception immediately following the final session on day one

DAY TWO | FRIDAY, JANUARY 26, 2018

8:00

Continental Breakfast

8:30

Chairperson’s Review of Day One

Katy Wong, RPh, MBA
Vice President, Producer Relations
CIGNA

8:45

Real World Therapy Management Program Response to PCSK9 Medications

Daniel Jude, PharmD, AAHIVP
Manager Specialty Clinical Services
Fairview Specialty Services Pharmacy

9:30

CASE STUDY Outcomes of a Voluntary Site of Care Program —
One Health Plan’s Experience

Leah King, PharmD, JD
Manager, Pharmacy Strategy
Highmark Inc.

10:15

Networking and Refreshment Break

10:45

ACA Update and Its Impact on Specialty Therapies

Melissa Andel
Health Policy Director
Applied Policy

11:30

Examining Drug Distribution Channels for Specialty Therapies

Carlos Alfaras
President and CEO
Gensco Pharma

12:15

Networking Luncheon

1:30

Considerations When Looking At Rare and Orphan Disease Treatments

Peter Dehnel
Medical Director
CentraCare HealthSystem

2:15

The Biosimilars Pipeline and Anticipated Access Barriers

Joseph Fuhr
Professor of Economics
Thomas Jefferson University

3:00

Chairperson’s Closing Remarks

Katy Wong, RPh, MBA
Vice President, Producer Relations
CIGNA

3:15

Close of Conference